Use

The Congenital Hyperinsulinism Panel is intended for individuals who have a clinical or suspected diagnosis of congenital hyperinsulinism (CHI), particularly those with disease onset in the neonatal period or early infancy. It is also useful for those with diazoxide-unresponsive hypoglycemia requiring aggressive medical management or for reproductive partners of individuals carrying a known pathogenic variant in CHI-associated genes.